ExchangeDEX+

Buy Crypto Markets Spot FuturesGOLD Earn Event Center

Commodity Zero-Fee Gala

TG Therapeutics, Inc. (TGTX)

NASDAQ

$28.75

$+0.83

(+2.99%)

TG Therapeutics, Inc. (TGTX) Live Price Chart

Page last updated: 2026-02-06 20:28:00

Key Market Data

Market Cap	$4.56B
Open	$28.25
High	$56.74
Low	$2.97
Previous Close	$27.76
Price Change	$+0.83
Percentage Change	+2.99%
Volume	840K

TG Therapeutics, Inc. (TGTX) Stock Price Today

TG Therapeutics, Inc. (TGTX) is currently trading at $28.75 as of 2026-02-06 20:28:00, reflecting a +2.99% move ($+0.83) from the previous close.

In the short term, the stock has returned -573.11% over the past four weeks. Over the last 12 months, TG Therapeutics, Inc. has recorded a -14.17% price change, indicating a weak performance relative to the broader market.

TG Therapeutics, Inc. (TGTX) 7-Day Stock Price Changes

Over the past seven days, TG Therapeutics, Inc. has traded within a short-term range shaped by market sentiment in the PHARMACEUTICAL PREPARATIONS sector. During this period, the stock moved from its previous closing price of $29.20 to the latest recorded price of $28.75, reflecting an intraday change of +2.99%. Daily movements highlight shifts in trading volume (839,602), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, TGTX has delivered a -573.11% return over the past month and a -14.17% change in the last 12 months, indicating a weak trend relative to its broader sector peers.

How to Buy TG Therapeutics, Inc. (TGTX)

You can buy and trade TGTX on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for TGTX and Execute Your Trade

Open the trading page, enter TGTX in the search bar, select the amount of TGTX you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is TG Therapeutics, Inc. (TGTX)?

TG Therapeutics Inc is a fully integrated, commercial-stage, biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases. The company has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS). In addition, it is developing TG-1701 (BTK inhibitor), Azer-Cel (allogeneic CD19 CAR T), and TG-1801 (anti-CD47/CD19 bispecific mAb) for B-cell disorders, which are under Phase 1 trials. Geographically, the company generates a majority of its revenue selling BRIUMVI in the United States, with the rest coming from sales in other countries.

TG Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	352
Sector	PHARMACEUTICAL PREPARATIONS
Company Website	https://www.tgtherapeutics.com

Frequently Asked Questions (FAQ)

1.What is the current share price of TG Therapeutics, Inc.?

The latest trading price for TG Therapeutics, Inc. (Common Stock) is $ 28.75, compared with a previous closing price of $ 27.76. That means the stock has moved +2.99% so far today. Intraday price updates and recent trading activity for TGTX can be tracked on the live chart and quote section on this page.

2.Is TG Therapeutics, Inc. stock going up or down?

Looking at recent performances, TGTX has returned -573.11% over the past month, +8.95% over the last six months and -14.17% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe weak price momentum for TG Therapeutics, Inc. stock, but keep in mind that past returns do not guarantee future results.

3.Where does TGTX currently sit relative to its 52-week high and low?

In the most recent 52-week period, TG Therapeutics, Inc. has traded between a low of $ 25.28 and a high of $ 46.48. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether TGTX is currently nearer the top or the bottom of its one-year trading band.

4.How is TG Therapeutics, Inc. classified by sector and industry?

TG Therapeutics, Inc. is classified in the PHARMACEUTICAL PREPARATIONS sector, within the PHARMACEUTICAL PREPARATIONS industry group and the PHARMACEUTICAL PREPARATIONS industry. In practice, this means TG Therapeutics, Inc. is grouped with companies that face similar end-markets, competitive dynamics and regulatory environments. For investors, knowing TGTX's sector and industry classification helps when building diversified portfolios, comparing TG Therapeutics, Inc. with direct peers, and understanding how stock-specific risks such as -- may be influenced by broader trends in the PHARMACEUTICAL PREPARATIONS sector and PHARMACEUTICAL PREPARATIONS industry.

5.Where is TG Therapeutics, Inc. listed and how large is it by market value?

TG Therapeutics, Inc. is listed on the NASDAQ stock exchange in United States. Based on a market capitalization of $ 4.56B, the company is classified as a Mid-cap stock. Market cap gives a quick sense of TG Therapeutics, Inc.'s size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.

6.What does TGTX's EPS tell investors about its profitability?

Trailing-twelve-month EPS of $ 2.82 summarises how much profit TG Therapeutics, Inc. has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track TG Therapeutics, Inc.'s financial performance over time?

To follow TG Therapeutics, Inc.'s financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how TGTX is performing and how the market is responding.

8.When is TG Therapeutics, Inc. expected to report earnings?

TG Therapeutics, Inc.'s next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for TGTX, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in TG Therapeutics, Inc.'s earnings reports?

TG Therapeutics, Inc.'s earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether TGTX is meeting, beating or missing expectations.

10.How can I stay informed about TG Therapeutics, Inc.'s results and guidance?

You can stay up to date on TG Therapeutics, Inc. by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for TGTX on this page helps you see how new information is being reflected in the stock.

11.Does TG Therapeutics, Inc. pay a regular cash dividend to its shareholders?

TG Therapeutics, Inc. Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of 0 at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor TGTX's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for TGTX?

Based on the latest earnings data, TGTX has a dividend yield of 0 and a dividend payout ratio of 0. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether TG Therapeutics, Inc. is an attractive income stock. The dividend payout ratio measures what percentage of earnings TG Therapeutics, Inc. distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is TG Therapeutics, Inc.?

TG Therapeutics, Inc. is a publicly traded company in the PHARMACEUTICAL PREPARATIONS industry within the PHARMACEUTICAL PREPARATIONS sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is TGTX valued in terms of P/E ratio and EPS?

TG Therapeutics, Inc. currently trades at a price-to-earnings (P/E) ratio of 9.85, based on trailing-twelve-month earnings per share (EPS) of $ 2.82. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of TG Therapeutics, Inc.'s earnings. Comparing TGTX's P/E and EPS to those of other PHARMACEUTICAL PREPARATIONS companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Stocks in the Same Sector

Browse other US stocks in the same sector as TG Therapeutics, Inc.

The Walt Disney Company

DIS

Largest Market Cap

See US stocks with the highest market capitalization

Berkshire Hathaway Inc.

BRK.A

Alphabet Inc.

GOOG

Most Actively Traded

Discover today's most actively traded US stocks

Aflac Inc.

AFL

Elevance Health, Inc.

ELV

Eaton Corporation, plc

ETN

KORE Group Holdings, Inc.

KORE

The Marcus Corporation

MCS

Top Gainers

Browse today's leading gainers in the US stock market

Bio Green Med Solution, Inc.

TuHURA Biosciences, Inc.

HURA

Jiuzi Holdings, Inc.

JZXN

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

BTC

ETH

SOL

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

TGTX-to-USD Calculator

Amount

TGTX

USD

1 TGTX = 28.752 USD